Nieuws
News article 4
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur congue mollis risus, imperdiet mollis velit convallis eu. Cras dui lorem, scelerisque at felis quis, convallis sodales ante.
First Clinical Trial with Genetically Modified Malaria Vaccine Completed
In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection.
Namens Nederland Opens Idea Platform for Young People Who Want to Tackle Rutte's Challenge
Het platform Namens Nederland (www.idee.namensnederland.nl) gaat inzichten en ideeën verzamelen van kinderen en jongeren die de uitdaging van premier Rutte willen aangaan. Tijdens zijn persconferentie riep de premier jongeren op om niet af te wachten, maar actief bij te dragen aan het oplossen van de coronacrisis.
Project Recovery During the COVID-19 Crisis
The outbreak of COVID-19 and the measures taken against it have raided us all.
Three More Projects Awarded in COVID-19 Call
COVID-19 was officially declared a pandemic on 11 March 2020. To prevent the disease from spreading, research projects have been set up at a rapid pace. Top Sector Life Sciences & Health has taken quick action to set up a COVID-19 call at the end of March. Three more projects have been awarded and are granted PPP Allowance to start their research.
Second Coronavirus Call for an Expression of Interest
This second call for an expression of interest complements the first expression of interest that the European Commission published in January 2020, which led to the funding of 18 projects in March 2020. The first expression of interest focused on advancing the knowledge on SARS-CoV-2 and its impact on infected persons, with the aim of contributing to an efficient patient management and/or public health preparedness and response.
Results: Impact of COVID-19 on Life Sciences Industry
This month ttopstart has interviewed 50 European life sciences companies on how they are impacted by and have responded to the COVID-19 crisis. In the report the results are discussed and translated into recommendations.
Mymetics and Baylor College of Medicine Start Research Collaboration Virosome-based COVID19 Vaccines
Mymetics, a pioneer and leader in the research and development of virosome-based vaccines against life threatening and life disabling diseases, has signed a Research Collaboration Agreement with Baylor College of Medicine and Texas Children’s Center for Vaccine Development. They will be evaluating their rationally designed recombinant protein-based SARS-CoV and SARS-CoV-2 antigens and combining them with Mymetics’ virosomes for the development of a safe and effective Covid-19 vaccine.
Leiden Joins Forces to Develop Improved Vaccines for Coronaviruses
De publieke-private samenwerking tussen het Leids Universitair Medisch Centrum (LUMC) en twee Leidse bedrijven, ISA Therapeutics en Immunetune, heeft 724.000 euro ontvangen van Topsector Life Sciences & Health (;Health~Holland). Het geld zal gebruikt worden om vaccins tegen het huidige coronavirus en andere coronavirussen te ontwikkelen.
Apply now for the second edition of the Health Impact Accelerator
Ben jij ondernemer en wil je met jouw innovatie bijdragen aan een gezonder Nederland? Wil jij jouw businessplan verder ontwikkelen samen met experts? Dan is de Health Impact Accelerator iets voor jou!